HEPATOCELLULAR CARCINOMA

This adverse event was reported 5407 times

These drugs are most commonly taken by patients reporting HEPATOCELLULAR CARCINOMA:

# Drug Count
0 SORAFENIB 1649
1 RIBAVIRIN 1043
2 SOFOSBUVIR 876
3 LEDIPASVIR AND SOFOSBUVIR 371
4 REGORAFENIB 368
5 FUROSEMIDE 193
6 TACROLIMUS 182
7 ENTECAVIR 180
8 SPIRONOLACTONE 169
9 TACROLIMUS CAPSULES 135
See all common drugs associated with HEPATOCELLULAR CARCINOMA